SOURCE: Dewmar International BMC, Inc.
HOUSTON, TX--(Marketwired - Feb 13, 2014) - Dewmar International BMC, Inc. (OTCQB: DEWM) (OTCBB: DEWM) ("Dewmar" or "Company") today announced that it has entered into a one year distribution agreement with C+SWISS, the original and first hemp-based ice tea ever distributed in the United States. The agreement gives Dewmar the exclusive right to distribute the hemp-based ice tea nationwide to one of the world's largest retailers. The distribution agreement, effective immediately, continues Dewmar's recently announced initiatives to become one of the most successful licensees and creators of hemp-based products in the United States.
The agreement was signed with Chill Drinks, LLC, a Miami, Florida-based company, and the creator of both the award-winning C+SWISS (hemp-based ice tea) and Chillo (hemp-based energy beverage). C+Swiss is an all-natural iced tea which is sold in both specialty and large retailers, including Whole Foods. The product is distributed in over 10 countries, experiencing over 30% sales growth in the past 7 years. Currently, over half of the sales from hemp-based products are within the food and beverage category.
"We have carefully selected this product for distribution, and Chill Drinks as a partner for four reasons," said Dr. Marco Moran, CEO of Dewmar International. "First, we are confident that Chill Drinks has the production and management capacity to meet a high volume of fulfillment, as we are hopeful for a significant increase in sales orders. Second, the product is excellent and we are confident that it will continue to gain popularity already existing with consumers. Third, the product contains hemp, which will be a major focus of our growth throughout 2014 into the functional food and beverage categories. Fourth, C+SWISS' packaging attracts consumers, and the branding ability of the product to stand on its own merit in a competitive environment of limited retail beverage shelf space was a major part of our decision. We are thrilled that we have entered into this exclusive licensing agreement."
Marc Lewin, Chief Executive Officer of Chill Drinks said, "There are many cities and towns in which C+SWISS is not yet on the shelf. We are confident that this distribution agreement will allow us to rapidly and strategically roll out C+SWISS into new markets and onto shelves for mainstream consumers, so that they can all enjoy the benefits of hemp and a great tasting beverage. We are confident that this relationship with Dewmar will result in great things for both companies."
Hemp has remarkable therapeutic benefits. The seeds contain a more complete amino acid profile than red meat and fish while the Omega-3 fatty acids can reduce the risk of cardiovascular disease and lower high blood pressure. Hemp is being studied in cancer, muscular sclerosis and whole host of other medical conditions.
Dewmar recently announced a co-branding and professional consulting agreement with a subsidiary of Hemp, Inc. (OTC Pink: HEMP), the Industrial Hemp and Medical Marijuana Consulting Company. As a result of the agreement, the Company will target thousands of smoke shops and head shops across the country simultaneously with multiple diverse product launches. Further details of these plans have not been unveiled at this time. "Dewmar's CEO has a work ethic second to none in that he has a voracious appetite to strategically plan for success then aggressively work the plan," says Hemp, Inc. CEO Bruce Perlowin. "As a partner with a vested interest in Dewmar's continued success, we are here to consult and guide them in a direction that allows them to maximize their limitless revenue potential within this exploding industry," Perlowin continues.
Also, Dewmar has recently announced expectations for significant Q1-2014 revenue growth for Lean Slow Motion Potion,™ the company's flagship product and one of the most successful brands in the relaxation beverage category. Dewmar also announced earlier this month that it will aggressively seek numerous partnerships, joint ventures, exclusive product licensing agreements and/or acquisitions of companies and product lines within the industrial hemp and medical marijuana sectors that will add value to the Company's bottom line within this calendar year. Based on recent developments, it is difficult for Dewmar to determine sales projections resulting from this new distribution deal at this time.
About Dewmar International BMC, Inc.
Dewmar International BMC, Inc. is a leading provider of consumer brands to global markets. The Company's flagship product, LEAN SLOW MOTION POTION™ whose three flavors are Yella, Purp and Easta Pink, is rated as one of the top 3 national selling relaxation beverages currently available in the U.S. market, Trinidad & Tobago, Puerto Rico and Mexico. The Company has entered into significant relationships and business discussions intended to leverage the explosion in national popularity of both the industrial hemp and medical marijuana industry, and forecasts a strong presence in the space for the immediate and long-term future. The company has offices in Clinton, MS; Houston, TX and Las Vegas, NV.
For more information about our Company please visit us at www.DewmarInternational.com. If you are a distributor or retailer inquiring about purchasing our product for resale, please contact us at 1-877-SIP-LEAN or 1-877-747-5326. If you are an Investor please contact us at InvestorRelations@DewmarInternational.com
About Chill Drinks, LLC
Chill Drinks, LLC is a privately owned, highly focused operating team aiming to shake up the beverage industry with a new line of imported hemp infused beverages that not only boast excellent flavors, but whose packaging jumps off the shelf; guaranteed to catch the consumer's eye. The Chill Drinks team has a background in importing and exporting consumer goods for over 30 years to North, Central and South America. With this experience, the Chill Drinks team is poised to bring about products, which will be game-changers in the beverage industry. Chill Drinks, LLC is based out of Miami, Florida and distributes C+SWISS, an all-natural hemp infused ice tea, and CHILLO, a hemp based energy beverage. Both drinks will be available in a sugar free version later on this year.
ABOUT HEMP, INC.
Hemp, Inc. (OTC Pink: HEMP) focuses on the vast market created by the quickly emerging, and growing, multibillion dollar industrial hemp industry. Hemp, Inc. (OTC Pink: HEMP) is not involved in the cultivation or marketing of medical marijuana. It is the company's belief that legalization of hemp in all 50 states and at the federal level will come to pass. With that in mind, the company is building infrastructure with the potential to gain substantial market share before and after industrial hemp prohibition ends. (Pending any federal licensing or other requirements, that may be enacted after hemp prohibition ends).
ABOUT THE INDUSTRIAL HEMP AND MEDICAL MARIJUANA CONSULTING COMPANY, INC.
The Industrial Hemp and Medical Marijuana Consulting Company (IHMMCC) is a wholly owned subsidiary of Hemp, Inc. (OTC Pink: HEMP) that pulls industry information from a vast network of specialists that consists of other public industry, public company CEOs, bankers, investors, lawyers, industry analysts, and non-profits connected to the industry. IHMMCC is entrenched in all the multi-faceted opportunities in the medical marijuana and Industrial Hemp industry. (www.HempInc.com)
Safe Harbor Statement
This news release contains forward looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources, general economic conditions and the impact of competitive pricing. In light of these uncertainties, the forward-looking events referred to in this release might not occur.